Insider Transactions Reported by 9 Insiders of Incannex Healthcare Inc.

Symbol
IXHL on Nasdaq
Location
Norwest Nsw

There are no Buy or Sell transactions made by insiders since 16 Mar 2025

Incannex Healthcare Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joel Latham CEO and President, Director $11,229,641 14 Nov 2025
Troy Valentine Director $5,729,051 14 Nov 2025
George Anastassov Director $1,140,635 14 Nov 2025
Peter Widdows Director $909,007 14 Nov 2025
Robert Clark Director $829,683 14 Nov 2025
Joseph Swan CFO, Treasurer and Secretary $427,786 14 Nov 2025
Madhukar Bhalla Secretary and CFO 28 Nov 2023
Lekhram Changoer Chief Technology Officer 28 Nov 2023
Luigi M. Barbato Chief Medical Officer 23 Oct 2024

Recent Insider Transactions by Companies or Individuals for Incannex Healthcare Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Troy Valentine IXHL Common Stock, $0.0001 par value per share Award 1616.4% 11,302,608 12,001,858 14 Nov 2025 Direct
Robert Clark IXHL Common Stock, $0.0001 par value per share Award 1687% 1,686,956 1,786,956 14 Nov 2025 Direct
Peter Widdows IXHL Common Stock, $0.0001 par value per share Award 622.8% 1,686,956 1,957,803 14 Nov 2025 Direct
Joseph Swan IXHL Common Stock, $0.0001 par value per share Award 1678.9% 869,565 921,358 14 Nov 2025 Direct
Joel Latham IXHL Common Stock, $0.0001 par value per share Award 1433.2% 22,608,692 24,186,177 14 Nov 2025 Direct
George Anastassov IXHL Common Stock, $0.0001 par value per share Award 219.2% 1,686,956 2,456,677 14 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.